Cocoa Extract for Migraine Trial
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Brigham and Women's Hospital
- Study ID
- NCT06808230
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Cocoa extract — DIETARY_SUPPLEMENTCocoa extract manufactured as 250 mg capsules
- Cocoa extract placebo — DIETARY_SUPPLEMENTCocoa extract placebo
Study Details
The goal of this clinical trial is to assess the feasibility of recruitment and adherence to a high-dose cocoa extract supplement in individuals diagnosed with episodic migraine. The main questions it aims to answer are: * Will we be able to enroll 114 participants during the recruitment period? * Will participants take study pills daily during the pill-taking period? Researchers will compare two doses of cocoa extract to placebo to determine the acceptability of higher doses of cocoa extract supplementation in this patient population. Participants will be asked to: * Provide two urine samples * Complete daily questionnaires * Take four study pills a day for 12 weeks
Key Dates
- Start date
- Jun 23, 2025
- Status verified
- Jul 2025
- Primary completion
- Dec 1, 2026
- Completion
- Dec 1, 2026
Study Design
- Enrollment
- 114 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- OTHER
Arms
- Placebo Comparator: PlaceboParticipants assigned to this arm will take four placebo pills per day.
- Experimental: 500 mg cocoa extractParticipants assigned to this arm will take two 250 mg cocoa extract pills per day and two placebo pills per day
- Experimental: 1000 mg cocoa extractParticipants assigned to this arm will take four 250 mg cocoa extract pills per day
Primary Outcome Measure
Recruitment [ Time Frame: 15 months ]
Central Contacts
- Pamela M Rist, ScD877-517-2555
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Brigham and Women's Hospital | Boston | Massachusetts | 02115 | Pamela M Rist, ScD |
Find similar trials in Boston, MA
Related Studies
- BE WELL With Migraine: Brain Education and WELLness With MigraineRecruiting · Wake Forest University Health Sciences · Cambridge, Massachusetts
- Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual MigrainePHASE3 · Recruiting · AbbVie · Birmingham, Alabama
- A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent MigrainePHASE3 · Recruiting · Pfizer · Phoenix, Arizona
- Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison StudyPHASE4 · Recruiting · Mayo Clinic · Flagstaff, Arizona